Russell Investments Group’s 4D Molecular Therapeutics FDMT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $80.9K | Buy |
21,816
+2,284
| +12% | +$8.47K | ﹤0.01% | 2875 |
|
|
2025
Q1 | $63.1K | Buy |
+19,532
| New | +$63.1K | ﹤0.01% | 2852 |
|
|
2024
Q4 | – | Sell |
-175
| Closed | -$1.89K | – | 3731 |
|
|
2024
Q3 | $1.89K | Sell |
175
-2,133
| -92% | -$23.1K | ﹤0.01% | 3384 |
|
|
2024
Q2 | $48.4K | Buy |
+2,308
| New | +$48.4K | ﹤0.01% | 2770 |
|
|
2023
Q4 | – | Sell |
-16
| Closed | -$204 | – | 3238 |
|
|
2023
Q3 | $204 | Sell |
16
-1,110
| -99% | -$14.2K | ﹤0.01% | 3495 |
|
|
2023
Q2 | $20.3K | Hold |
1,126
| – | – | ﹤0.01% | 2838 |
|
|
2023
Q1 | $19.4K | Sell |
1,126
-443
| -28% | -$7.62K | ﹤0.01% | 2817 |
|
|
2022
Q4 | $34.8K | Hold |
1,569
| – | – | ﹤0.01% | 2759 |
|
|
2022
Q3 | $12K | Buy |
+1,569
| New | +$12K | ﹤0.01% | 2849 |
|
|
2022
Q2 | – | Sell |
-742
| Closed | -$11K | – | 2914 |
|
|
2022
Q1 | $11K | Sell |
742
-56,197
| -99% | -$833K | ﹤0.01% | 2705 |
|
|
2021
Q4 | $1.25M | Sell |
56,939
-45,778
| -45% | -$1M | ﹤0.01% | 2041 |
|
|
2021
Q3 | $2.77M | Buy |
+102,717
| New | +$2.77M | ﹤0.01% | 1633 |
|